Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dihydropyridine depot formulation

Dihydropyridine depot formulation

US Patent 4933186 · Granted Jun 12, 1990

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical formulation comprising one or more fumaric acid esters in an eros2021
DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising 2021
Surface-treated calcium carbonate filler for curable resin composition, and cura2019
DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising 2018
Pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotens2018
DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising 2016
DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising 2015
Pharmaceutical formulation comprising one or more fumaric acid esters in an eros2014
Medicaments containing vardenafil hydrochloride trihydrate2014
Method for solubilizing molybdenum oxide concentrates2013
Medicaments containing vardenafil hydrochloride trihydrate2012
Sustained-release preparations of quinolone antibiotics2012